Deshmukh A, Srivastava S, Herrmann S, Gupta A, Mitra P, Gilberger T
Nucleic Acids Res. 2012; 40(12):5313-31.
PMID: 22379140
PMC: 3384324.
DOI: 10.1093/nar/gks202.
Lopez-Bergami P, Lau E, Ronai Z
Nat Rev Cancer. 2009; 10(1):65-76.
PMID: 20029425
PMC: 2874064.
DOI: 10.1038/nrc2681.
Steff A, Carillo S, Pariat M, Piechaczyk M
Biochem J. 1997; 323 ( Pt 3):685-92.
PMID: 9169601
PMC: 1218371.
DOI: 10.1042/bj3230685.
Skinner M, Qu S, Moore C, Wisdom R
Mol Cell Biol. 1997; 17(5):2372-80.
PMID: 9111306
PMC: 232086.
DOI: 10.1128/MCB.17.5.2372.
Funk M, Poensgen B, GRAULICH W, Jerome V, Muller R
Mol Cell Biol. 1997; 17(2):537-44.
PMID: 9001206
PMC: 231778.
DOI: 10.1128/MCB.17.2.537.
Myristylation of FBR v-fos dictates the differentiation pathways in malignant osteosarcoma.
Jotte R, Holt J
J Cell Biol. 1996; 135(2):457-67.
PMID: 8896601
PMC: 2121035.
DOI: 10.1083/jcb.135.2.457.
Antisense rescue defines specialized and generalized functional domains for c-Fos protein.
Holt J
Mol Cell Biol. 1993; 13(6):3821-30.
PMID: 8497282
PMC: 359870.
DOI: 10.1128/mcb.13.6.3821-3830.1993.
Proto-oncogene FosB: the amino terminus encodes a regulatory function required for transformation.
Wisdom R, Verma I
Mol Cell Biol. 1993; 13(5):2635-43.
PMID: 8474434
PMC: 359630.
DOI: 10.1128/mcb.13.5.2635-2643.1993.
Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function.
Stein B, Baldwin Jr A, Ballard D, Greene W, Angel P, Herrlich P
EMBO J. 1993; 12(10):3879-91.
PMID: 8404856
PMC: 413671.
DOI: 10.1002/j.1460-2075.1993.tb06066.x.
Transformation by the fos or jun oncogene does not increase AP-1 DNA-binding activity.
Hawker K, Pintzas A, Hennigan R, Gillespie D, Ozanne B
J Virol. 1993; 67(9):5487-95.
PMID: 8350408
PMC: 237951.
DOI: 10.1128/JVI.67.9.5487-5495.1993.
Cell transformation by c-fos requires an extended period of expression and is independent of the cell cycle.
Miao G, Curran T
Mol Cell Biol. 1994; 14(6):4295-310.
PMID: 8196666
PMC: 358796.
DOI: 10.1128/mcb.14.6.4295-4310.1994.
An autonomous N-terminal transactivation domain in Fos protein plays a crucial role in transformation.
Jooss K, Funk M, Muller R
EMBO J. 1994; 13(6):1467-75.
PMID: 8137828
PMC: 394966.
DOI: 10.1002/j.1460-2075.1994.tb06401.x.
Positive and negative regulation of the composite octamer motif of the interleukin 2 enhancer by AP-1, Oct-2, and retinoic acid receptor.
de Grazia U, Felli M, Vacca A, Farina A, Maroder M, Cappabianca L
J Exp Med. 1994; 180(4):1485-97.
PMID: 7931079
PMC: 2191694.
DOI: 10.1084/jem.180.4.1485.
An inhibitor domain in c-Fos regulates activation domains containing the HOB1 motif.
Brown H, Sutherland J, Cook A, Bannister A, Kouzarides T
EMBO J. 1995; 14(1):124-31.
PMID: 7828584
PMC: 398059.
DOI: 10.1002/j.1460-2075.1995.tb06982.x.
Purification and characterization of interferon-like antiviral protein derived from flatfish (Paralichthys olivaceus) lymphocytes immortalized by oncogenes.
Tamai T, Shirahata S, Sato N, Kimura S, Nonaka M, Murakami H
Cytotechnology. 1993; 11(2):121-31.
PMID: 7686026
DOI: 10.1007/BF00749001.
Immortalization of human lymphocytes by transfection with DNA from mouse L929 cytoplasts.
Abken H, Butzler C, Willecke K
Proc Natl Acad Sci U S A. 1988; 85(2):468-72.
PMID: 3257567
PMC: 279571.
DOI: 10.1073/pnas.85.2.468.
Fos C-terminal mutations block down-regulation of c-fos transcription following serum stimulation.
Wilson T, Treisman R
EMBO J. 1988; 7(13):4193-202.
PMID: 3149583
PMC: 455132.
DOI: 10.1002/j.1460-2075.1988.tb03316.x.
fra-1: a serum-inducible, cellular immediate-early gene that encodes a fos-related antigen.
Cohen D, Curran T
Mol Cell Biol. 1988; 8(5):2063-9.
PMID: 3133553
PMC: 363385.
DOI: 10.1128/mcb.8.5.2063-2069.1988.
Control of myogenic differentiation by cellular oncogenes.
Schneider M, Olson E
Mol Neurobiol. 1988; 2(1):1-39.
PMID: 3077064
DOI: 10.1007/BF02935631.
Structural and functional domains of the myb oncogene: requirements for nuclear transport, myeloid transformation, and colony formation.
Ibanez C, Lipsick J
J Virol. 1988; 62(6):1981-8.
PMID: 2835503
PMC: 253282.
DOI: 10.1128/JVI.62.6.1981-1988.1988.